Evercore ISI raises FormFactor stock price target on networking ramps

Evercore ISI lifted its FormFactor price target to $133 from $80 while keeping an In Line rating, citing networking/CPO ramps, CPU recovery, and GPU share gains, but warned upside may be capped by 2026 manufacturing capacity constraints. FormFactor also beat Q4 2025 expectations with EPS of $0.46 versus $0.35 consensus and revenue of $215.2 million versus $210.25 million. Cantor Fitzgerald separately raised its target to $175 and maintained Overweight, highlighting continued demand despite capacity concerns.

Analysis

The key takeaway is not that AI demand is still strong; it is that the market is beginning to differentiate between beneficiaries with pricing power and those with already-discounted growth. A name like FORM can keep working fundamentally, but when valuation is sitting on a large premium to the market and the stock has already re-rated hard, the next leg becomes much more dependent on supply discipline and execution than on the headline AI cycle. That makes the setup asymmetrical: good news may no longer translate into multiple expansion, while any delay in capacity relief could cap upside for several quarters.

Second-order, the real trade here is likely in the ecosystem rather than the obvious AI leaders. If test/inspection and photonics-adjacent suppliers are constrained, the bottleneck shifts bargaining power toward customers that can secure capacity early and away from smaller peers that need the same nodes but lack allocation leverage. That usually shows up months later as share gains for the best-capitalized platforms and margin pressure for suppliers that are forced to choose between volume and price; the market often misses this until bookings inflect unevenly across the chain.

The contrarian read is that the setup may be less about a broken AI demand story and more about a crowded consensus trade needing a pause. When a stock has already rerated sharply, analysts tend to chase target raises after the move, which can extend the narrative but not necessarily improve forward returns. The risk is a digestion phase of 1-3 quarters where fundamentals remain fine, but the multiple mean-reverts before the next capacity wave can re-accelerate the stock.

Key Decisions for Investors

• Fade strength in FORM via a tactical short or put spread on any post-upgrade pop; 1-3 month horizon, because the risk/reward is skewed once the market has already priced in multiple tailwinds and capacity is the gating item.
• For investors needing AI exposure, rotate from over-owned hardware enablers into higher-quality platform beneficiaries with less manufacturing bottleneck risk; use FORM relative strength as a source of funds rather than adding at elevated multiples.
• Pair trade: long a cash-generative AI infrastructure beneficiary with visible 2026 capacity expansion, short FORM, targeting normalization in relative valuation over 2-4 quarters if the market starts discounting the capacity ceiling.
• Use call spreads instead of outright longs in FORM if initiating exposure, because upside is likely to be capped by valuation and supply constraints; that structure preserves participation while limiting theta bleed if the stock consolidates.
• Set a tight review trigger around the next capacity/booking commentary; if management language shifts from demand bottleneck to pricing pressure, expect a fast 10-15% de-rating window.